Objective-To determine how severe tricuspid regurgitation influences exercise capacity and functional state in patients who have undergone successful mitral valve replacement for rheumatic mitral valve disease.
Abstract
Objective-To determine how severe tricuspid regurgitation influences exercise capacity and functional state in patients who have undergone successful mitral valve replacement for rheumatic mitral valve disease.
Design-9 patients in whom clinically significant tricuspid regurgitation developed late after mitral valve replacement were compared with 9 patients with no clinical evidence of tricuspid regurgitation. The two groups were matched for preoperative clinical and haemodynamic variables. Patients were assessed by conventional echocardiography, Doppler echocardiography, and a maximal treadmill exercise test in which expired gas was monitored by mass spectrometry.
Setting-University Hospital of Wales, Cardiff.
Subjects-18 patients who had been reviewed regularly since mitral valve replacement.
Main outcome measure-Objective indices of exercise performance including exercise duration, maximal oxygen consumption, anaerobic threshold, and ventilatory response to exercise.
Results-Mitral valve prosthetic function was normal in all patients and estimated pulmonary artery systolic pressure and left ventricular function were similar in the two groups. Right ventricular diameter (median (range) 5.0 (4 3-5 6) v 3-7 (3 0-5 4) cm, p < 001) and the incidence of paradoxical septal motion (9/9 v 3/9, p < 0O01) were greater in the group with severe tricuspid regurgitation. Exercise performance-assessed by exercise duration (6-3 (5@010-7) v 12-7 (7-2-16-0) min, p < 0O01), maximum oxygen consumption (11-2 (7-3-17-8) v (11-8-214 ) ml min-' kg-', p < 0O01), and anaerobic threshold (46-l11-4) v 07 (7-3-15-5) ml min-' kg-', p < 005)-was significantly reduced in the group with severe tricuspid regurgitation. The ventilatory response to exercise was greater in patients with tricuspid regurgitation (minute ventilation at the same minute carbon dioxide production (410 (29 9-59 5) v (26-8-39 3) l/min, p < 001). patients with heart failure.9 10 It is also valuable as a method of assessing accurately the severity of cardiac disease and correlating this with the extent of functional limitation." 12 The aim of this study was to establish by exercise testing with expired gas analysis how the presence of severe tricuspid regurgitation influenced exercise capacity and functional state in patients who had undergone successful mitral valve replacement for rheumatic mitral valve disease.
Patients and methods Eighteen patients were studied; nine (eight women, one man) had developed clinically significant tricuspid regurgitation late after successful mitral valve replacement for rheumatic mitral valve disease. Their mean age was 59 years (range 48-67). All patients had experienced an initial symptomatic improvement after operation but they described the return of limiting symptoms when clinical signs of tricuspid regurgitation became apparent. Clinically significant tricuspid regurgitation was diagnosed in the presence of a raised jugular venous pressure with prominent cv wave, pulsatile hepatomegaly, and fluid retention requiring intensive diuretic treatment. Nine patients (eight women, one man) who had also undergone mitral valve replacement for rheumatic mitral valve disease were chosen as a closely matched control group. Their mean age was 62 years (range 56-67). When we selected these patients we attempted to match clinical, preoperative haemodynamic, operative, and current echocardiographic indices as closely as possible (tables 1 and 2). None had clinical signs of tricuspid regurgitation or a history of postoperative fluid retention. All patients in both groups were in atrial fibrillation.
Patients were questioned about current cardiac symptoms, and functional capacity was assessed according to the New York Heart Association (NYHA) classification. During clinical examination we noted the presence or absence of physical signs suggesting tricuspid regurgitation. The The left ventricular dimensions were recorded in the long axis view as the greatest dimensions of the left ventricle obtained at the level of the mitral valve prosthesis. The minor axis dimensions were measured between the endocardial surfaces of the posterior wall and interventricular septum. The end diastolic dimension (EDD) was taken at the peak of the R wave of the simultaneously recorded electrocardiogram. The end systolic dimension (ESD) was defined as the minimum distance separating the endocardial surfaces at the peak upward anterior motion of the posterior ventricular wall. Fractional shortening was calculated by the following formula:
LVEDD -LVESD FS (%) = LVEDD x 100 LVEDD The right ventricular end diastolic dimension was measured as the distance between the endocardial surfaces of the right ventricle at the R wave of the simultaneously recorded electrocardiogram. The direction of septal motion in early systole was recorded and judged to be either normal or paradoxical.
Prosthetic valve function was studied by visual inspection of the cross sectional echocardiogram and by Doppler assessment. Continuous wave Doppler signals of diastolic mitral flow velocity were recorded and an estimate of mitral valve area was derived from the pressure half time. Mitral regurgitation was sought by pulsed wave echocardiography and colour flow Doppler mapping in apical and left parasternal views.
Tricuspid regurgitation was detected in all 18 subjects and was apparent with both continuous wave and colour flow Doppler. Doppler recordings of maximal velocity were obtained from the apical and left parasternal views and continuous wave Doppler signals were considered optimal once the maximum clearly defined spectral envelope was achieved. The peak velocity (v) of the tricuspid regurgitation jet was used to calculate the systolic tricuspid valve gradient from a modified Bernoulli equation:
TV gradient (mm Hg) = 4 v2 The systolic pressure gradient across the tricuspid valve represents the difference between the right ventricular and right atrial systolic pressures. The right ventricular systolic pressure (and also pulmonary artery systolic pressure) can therefore be estimated if the pressure gradient and right atrial pressure are known.'3 Right atrial pressure was estimated by adding 5 reductions in maximal oxygen consumption920 and anaerobic tha-eshold20 21 reflect an impaired overall cardiac output response to exercise in patients with heart failure. This is also presumably the mechanism by which exercise capacity is reduced in patients with tricuspid regurgitation-that is, by limiting the increase in right ventricular cardiac output that can be achieved during exercise. Our findings, however, do not enable us to determine whether this is because of a progressively failing right ventricle, of which tricuspid regurgitation is merely a marker, or whether a large tricuspid regurgitant fraction is itself primarily responsible for a reduction in forward flow. In either case, our results corroborate evidence suggesting that events in the right heart are important in determining exercise capacity. '6 It is not clear why significant tricuspid regurgitation developed in these patients. Echocardiography showed thickening of the tricuspid valve in two thirds of the patients with clinically significant tricuspid regurgitation; but this was also a common finding among those in the control group and was never accompanied by abnormal cusp motion. Thickening of the tricuspid valve is a non-specific finding at echocardiography and the c:: ,s sectional echocardiogram is generally able to identify when it is accompanied by valve stenosis and is a feature of organic rheumatic tricuspid valve disease.22 In the absence, therefore, of organic tricuspid valve disease, we assume that tricuspid regurgitation is functional in these patients. Neither significant pulmonary arterial nor venous hypertension were present and it is likely, therefore, that severe functional tricuspid regurgitation develops either as a result of progressive right ventricular dysfunction or as a result of persistent dilatation of the tricuspid valve annulus. Because we studied these patients when the consequences of severe tricuspid regurgitation were likely to be advanced, it is difficult to determine which is most likely. Right ventricular dysfunction could develop as a result of tricuspid regurgitation but the reverse is also true. This difficult question has important therapeutic implications. Surgical correction of tricuspid regurgitation may be of some benefit if persistent annular dilatation is the dominant underlying abnormality, while it may be no help or even detrimental ifannular dilatation is secondary to right ventricular dysfunction.
King et al retrospectively analysed their results of surgery for tricuspid regurgitation that developed late after mitral valve replacement.23 Of 32 patients, 14 had no evidence of prosthetic valve dysfunction or significant aortic valve disease; however, they did not comment on indices of left ventricular function or pulmonary artery systolic pressure in these patients. Tricuspid valve replacement was performed in 11 patients while three underwent tricuspid valve annuloplasty. Only four patients, however, improved by at least one NYHA class, while three patients died in the early postoperative period because of a low cardiac output and six died during the following six years. One patient remained in NYHA class IV. They concluded that tricuspid regurgitation developing late after mitral valve replacement in their patients was a manifestation of right ventricular failure and that restoring tricuspid valve competence was of little benefit. Though their results are certainly disappointing, we cannot conclude that tricuspid valve surgery has no part in the management of this heterogeneous group. It may be, for example, that patients with a relatively low pulmonary artery systolic pressure and well preserved left ventricular function would experience better results from tricuspid valve repair or replacement. Certainly, before dismissing the role of surgery, it would be necessary prospectively to study the benefits of correcting tricuspid regurgitation, both on functional state and on outcome, in patients with severe tricuspid regurgitation but without pulmonary hypertension, left ventricular dysfunction, or prosthetic valve failure.
Of perhaps more importance, given the apparent high mortality of reoperation on the tricuspid valve23 and the considerable functional limitation that we showed in these patients, is that much is to be gained in attempting to reduce the likelihood of severe tricuspid regurgitation developing after mitral valve replacement. This may best be achieved by the accurate detection and correction of important tricuspid regurgitation at initial surgery. Tricuspid regurgitation is a common finding in patients with advanced mitral stenosis or regurgitation and may be present in London: Churchill, 1880:141.
